Cerba research, assay serum biomarkers
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00145
- Awardee
-
Cerba Research Usa, Inc. UEI W15NDJ1DSXN9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $66,334
Award facts
- Opportunity
-
- 75N92020Q0099 Solicitation number
- Cerba Research, Clinical Chemistry Panel in West A Award Notice · Posted Jun 16, 2021
- Contract value 100% obligated
- $66,333.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New Hyde Park, NY 11042, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $66,334 |
About this award
The National Heart Lung and Blood Institute awarded a $66,333.75 firm fixed-price purchase order to Cerba Research USA, Inc. on June 16, 2021, for cerba research and assay serum biomarkers work. The contract, which has no set-aside designation, is scheduled for completion by June 30, 2022, and will be performed at the contractor's laboratory facility in New Hyde Park, New York. Cerba Research USA, Inc. is a CLIA-certified clinical laboratory service provider specializing in biomedical research support and clinical trial services.
This award represents one of several federal contracts Cerba Research has received from the National Institutes of Health and affiliated institutes for clinical laboratory testing and biomarker analysis. The company maintains established relationships with multiple NIH institutes and brings relevant expertise in serum biomarker assays and clinical laboratory services. As the sole awardee with no identified subcontractors, Cerba Research will deliver the contracted services directly from its New York-based laboratory operations.
Quick answers
Who was awarded contract 75N92021P00145?
75N92021P00145 was awarded to Cerba Research Usa, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on June 16, 2021.
How much is contract 75N92021P00145 worth?
The government has obligated $66,334 on 75N92021P00145.
Was contract 75N92021P00145 competed?
The extent of competition for 75N92021P00145 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award